DPP4 and diabetes mellitus: Collectively, our findings reveal that the suppression of DPP4 expression in adipose tissue and DPP4 activity in plasma with nondiabetic plasma-treated SVFs may ultimately attenuate glucose intolerance and insulin resistance in diabetes.